IGF1 and hypertrophic cardiomyopathy: The GRS for lower FEV1/FVC specific to the hypertrophic cardiomyopathy pathway was associated with reduced liver enzymes (ALT and GGT) as well as lower apolipoprotein B, LDL, IGF-1 and mean platelet volume (Fig. 6).